N/A
Manufactured by Advanced Rx LLC
32,440 FDA adverse event reports analyzed
Last updated: 2026-04-14
MECLIZINE HCL 12.5 MG is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Advanced Rx LLC. The most commonly reported adverse reactions for MECLIZINE HCL 12.5 MG include DIZZINESS, NAUSEA, FATIGUE, DIARRHOEA, FALL. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MECLIZINE HCL 12.5 MG.
Out of 13,192 classified reports for MECLIZINE HCL 12.5 MG:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.